Visceral fat and its dynamic change are associated with renal damage: Evidence from two cohorts

References

• Herzog CA, Asinger RW, Berger AK, Charytan DM, Díez J, Hart RG, Eckardt K-U, Kasiske BL, McCullough PA, Passman RS, et al. Cardiovascular disease in chronic kidney disease. A clinical update from kidney disease: improving Global outcomes (KDIGO). Kidney Int. 2011;80(6):572–8. doi:10.1038/ki.2011.223.
   PubMed Web of Science ®Google Scholar
• Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJL, Mann JF, Matsushita K, Wen CP. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52. doi:10.1016/S0140-6736(13)60595-4.
   PubMed Web of Science ®Google Scholar
• Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, Hobbs FDR. Global prevalence of chronic kidney disease – a systematic review and meta-analysis. PloS One. 2016;11(7):e0158765. doi:10.1371/journal.pone.0158765.
   PubMed Web of Science ®Google Scholar
• Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulkader RS, Abdulle AM, Abebo TA, Abera SF, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global burden of disease study 2016. Lancet. 2017;390(10100):1211–59. doi:10.1016/S0140-6736(17)32154-2.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, et al. Prevalence of chronic kidney disease in China: a cross-sectional surve. Lancet. 2012;379(9818):815–22. doi:10.1016/S0140-6736(12)60033-6.
   PubMed Web of Science ®Google Scholar
• Lv JC, Zhang LX. Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol. 2019;1165:3–15.
   PubMed Web of Science ®Google Scholar
• Lakkis JI, Weir MR. Obesity and kidney disease. Prog Cardiovasc Dis. 2018;61(2):157–67. doi:10.1016/j.pcad.2018.07.005.
   PubMed Web of Science ®Google Scholar
• Noori N, Hosseinpanah F, Nasiri AA, Azizi F. Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J Ren Nutr. 2009;19(3):228–37. doi:10.1053/j.jrn.2008.11.005.
   PubMed Web of Science ®Google Scholar
• Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, adipose tissue and vascular dysfunction. Circ Res. 2021;128(7):951–68. doi:10.1161/CIRCRESAHA.121.318093.
   PubMed Web of Science ®Google Scholar
• González N, Moreno-Villegas Z, González-Bris A, Egido J, Lorenzo Ó. Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes. Cardiovasc Diabetol. 2017;16(1):44. doi:10.1186/s12933-017-0528-4.
   PubMed Web of Science ®Google Scholar
• Xia MF, Chen Y, Lin HD, Ma H, Li X-M, Aleteng Q, Li Q, Wang D, Hu Y, Pan B-S, et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Sci Rep. 2016;6(1):38214. doi:10.1038/srep38214.
   PubMedGoogle Scholar
• Bi H, Zhang Y, Qin P, Wang C, Peng X, Chen H, Zhao D, Xu S, Wang L, Zhao P, et al. Association of Chinese visceral adiposity index and its dynamic change with risk of carotid plaque in a large cohort in China. J Am Heart Assoc. 2022;11(1):e022633. doi:10.1161/JAHA.121.022633.
   PubMed Web of Science ®Google Scholar
• Li B, Wang J, Zhou X, Liu Y, Wang W, Gao Z, Tang X, Yan L, Wan Q, Luo Z, et al. Chinese visceral adiposity index is more closely associated with hypertension and prehypertension than traditional adiposity indices in Chinese population: results from the REACTION study. Front Endocrinol (Lausanne). 2022;13:921997.
   PubMed Web of Science ®Google Scholar
• Huang YC, Huang JC, Lin CI, Chien H-H, Lin Y-Y, Wang C-L, Liang F-W, Dai C-Y, Chuang H-Y. Comparison of innovative and traditional cardiometabolic indices in estimating atherosclerotic cardiovascular disease risk in adults. Diagnostics (Basel). 2021;11(4):603. doi:10.3390/diagnostics11040603.
   PubMedGoogle Scholar
• Seong JM, Lee JH, Gi MY, Son YH, Moon AE, Park CE, Sung HH, Yoon H. Gender difference in the association of chronic kidney disease with visceral adiposity index and lipid accumulation product index in Korean adults: Korean National Health and Nutrition Examination Survey. Int Urol Nephrol. 2021;53(7):1417–25. doi:10.1007/s11255-020-02735-0.
   PubMed Web of Science ®Google Scholar
• Xiao H, Xiong C, Shao X, Gao P, Chen H, Ning J, Chen Y, Zou Z, Hong G, Li X, et al. Visceral adiposity index and chronic kidney disease in a non-diabetic population: a cross-sectional study. Diabetes Metab Syndr Obes. 2020Vol. 13pp. 257–65 p.
   PubMed Web of Science ®Google Scholar
• Chen YC, Lai SH, Tsai YW, Chang S-S. Visceral adiposity index as a predictor of chronic kidney disease in a relatively healthy population in Taiwan. J Ren Nutr. 2018;28(2):91–100. doi:10.1053/j.jrn.2017.07.006.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Liu K, Zheng M, Chen S, Wang H, Jiang Q, Xiao Y, Zhou L, Liu X, Yu Y, et al. Analysis of changes in weight, waist circumference, or both, and all-cause mortality in Chinese adults. JAMA Netw Open. 2022;5(8):e2225876. doi:10.1001/jamanetworkopen.2022.25876.
   PubMed Web of Science ®Google Scholar
• Huang YY, Jiang CQ, Xu L, Zhang WS, Zhu F, Jin YL, Thomas GN, Cheng KK, Lam TH. Adiposity change and mortality in middle-aged to older Chinese: an 8-year follow-up of the Guangzhou biobank cohort study. BMJ Open. 2020;10(12):e039239. doi:10.1136/bmjopen-2020-039239.
   PubMed Web of Science ®Google Scholar
• Chen C, Ye Y, Zhang Y, Pan X-F, Pan A. Weight change across adulthood in relation to all cause and cause specific mortality: prospective cohort study. Bmj. 2019;367:l5584. doi:10.1136/bmj.l5584.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China health and Retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43(1):61–68. doi:10.1093/ije/dys203.
   PubMed Web of Science ®Google Scholar
• Ma YC, Zuo L, Chen JH, Luo Q, Yu X-Q, Li Y, Xu J-S, Huang S-M, Wang L-N, Huang W, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–44. doi:10.1681/ASN.2006040368.
   PubMed Web of Science ®Google Scholar
• Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison. Diab Care. 2006;29(1):151–53. doi:10.2337/diacare.29.01.06.dc05-1805.
   PubMed Web of Science ®Google Scholar
• Chang Y, Guo X, Li T, Li S, Guo J, Sun Y. A body shape index and body Roundness index: two New body indices to identify left ventricular hypertrophy among rural populations in Northeast China. Heart Lung Circ. 2016;25(4):358–64. doi:10.1016/j.hlc.2015.08.009.
   PubMed Web of Science ®Google Scholar
• Xia MF, Lin HD, Chen LY, Wu L, Ma H, Li Q, Aleteng Q, Chen Y, Sun Y-X, Hu Y, et al. Association of visceral adiposity and its longitudinal increase with the risk of diabetes in Chinese adults: a prospective cohort study. Diabetes Metab Res Rev. 2018;34(7):e3048. doi:10.1002/dmrr.3048.
   PubMed Web of Science ®Google Scholar
• Wei J, Liu X, Xue H, Wang Y, Shi Z. Comparisons of visceral adiposity index, body shape index, body Mass index and waist circumference and their associations with diabetes mellitus in adults. Nutrients. 2019;11(7):1580. doi:10.3390/nu11071580.
   PubMed Web of Science ®Google Scholar
• Wan H, Wang Y, Xiang Q, Fang S, Chen Y, Chen C, Zhang W, Zhang H, Xia F, Wang N, et al. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020;19(1):118. doi:10.1186/s12933-020-01095-4.
   PubMed Web of Science ®Google Scholar
• Lin M, Li N, Heizhati M, Gan L, Zhu Q, Yao L, Li M, Yang W. Chinese visceral adiposity index is associated with incident renal damage in patients with hypertension and abnormal glucose metabolism: a longitudinal study. Front Endocrinol (Lausanne). 2022;13:910329. doi:10.3389/fendo.2022.910329.
   PubMed Web of Science ®Google Scholar
• Vlassopoulos A, Combet E, Lean ME. Changing distributions of body size and adiposity with age. Int J Obes (Lond). 2014;38(6):857–64. doi:10.1038/ijo.2013.216.
   PubMed Web of Science ®Google Scholar
• Chung HF, Al Mamun A, Huang MC, Long KZ, Huang Y-F, Shin S-J, Hwang S-J, Hsu C-C. Obesity, weight change, and chronic kidney disease in patients with type 2 diabetes mellitus: a longitudinal study in Taiwan. J Diabetes. 2017;9(11):983–93. doi:10.1111/1753-0407.12514.
   PubMed Web of Science ®Google Scholar
• Hu S, Li X, Sun Y, Wu S, Lan Y, Chen S, Wang Y, Liao W, Wang X, Zhang D, et al. Short-term weight loss decreased the risk of chronic kidney disease in men with incident nonalcoholic fatty liver disease. Obesity (Silver Spring). 2022;30(7):1495–506. doi:10.1002/oby.23459.
   PubMed Web of Science ®Google Scholar
• Baria F, Kamimura MA, Aoike DT, Ammirati A, Leister Rocha M, de Mello MT, Cuppari L. Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrol Dial Transplant. 2014;29(4):857–64. doi:10.1093/ndt/gft529.
   PubMed Web of Science ®Google Scholar
• Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study. Int J Obes (Lond). 2019;43(1):139–48. doi:10.1038/s41366-018-0076-3.
   PubMed Web of Science ®Google Scholar
• Sarafidis PA, Ruilope LM. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol. 2006;26(3):232–44. doi:10.1159/000093632.
   PubMed Web of Science ®Google Scholar
• Izquierdo-Lahuerta A, Martínez-García C, Medina-Gómez G. Lipotoxicity as a trigger factor of renal disease. J Nephrol. 2016;29(5):603–10. doi:10.1007/s40620-016-0278-5.
   PubMed Web of Science ®Google Scholar
• Joles JA, Kunter U, Janssen U, KRIZ W, RABELINK TJ, KOOMANS HA, FLOEGE J. Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol. 2000;11(4):669–83. doi:10.1681/ASN.V114669.
   PubMed Web of Science ®Google Scholar
• Ruan XZ, Varghese Z, Moorhead JF. An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol. 2009;5(12):713–21. doi:10.1038/nrneph.2009.184.
   PubMed Web of Science ®Google Scholar
• Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021;320(3):C375–c391. doi:10.1152/ajpcell.00379.2020.
   PubMed Web of Science ®Google Scholar
• Sakaguchi Y, Shoji T, Kawabata H, Niihata K, Suzuki A, Kaneko T, Okada N, Isaka Y, Rakugi H, Tsubakihara Y, et al. High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study. Clin J Am Soc Nephrol. 2011;6(5):995–1000. doi:10.2215/CJN.08670910.
   PubMed Web of Science ®Google Scholar
• Dinh Cat AN, Friederich-Persson M, White A, Touyz RM. Adipocytes, aldosterone and obesity-related hypertension. J Mol Endocrinol. 2016;57(1):F7–f21. doi:10.1530/JME-16-0025.
   PubMed Web of Science ®Google Scholar
• Goossens GH, Blaak EE, van Baak MA. Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. Obes Rev. 2003;4(1):43–55. doi:10.1046/j.1467-789X.2003.00091.x.
   PubMedGoogle Scholar